Poseida Therapeutics (PSTX) SEC Filings & 10K Form $3.08 +0.15 (+5.12%) (As of 11/8/2024 ET) Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Recent Poseida Therapeutics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView09/30/20247:00 AMPoseida Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/14/202411:15 PMPoseida Therapeutics (Filer)Form EFFECT06/07/202412:30 PMBlackRock Inc. (Filed by)Poseida Therapeutics (Subject)Form SC 13G/A05/14/20243:06 PMPoseida Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/05/202411:15 PMPoseida Therapeutics (Filer)Form EFFECT05/01/20248:07 AMPoseida Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/17/20248:17 AMPoseida Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/08/20244:01 PMPoseida Therapeutics (Filer)Form S-3Registration statement under Securities Act of 1933 04/08/20243:30 PMPoseida Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/04/20244:29 PMMylet Johanna (Reporting)Poseida Therapeutics (Issuer)Form 4Statement of changes in beneficial ownership of securities 02/09/20248:28 AMFMR LLC (Filed by)Poseida Therapeutics (Subject)Form SC 13G/A02/08/20243:10 PMPoseida Therapeutics (Filer)Form S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans 02/02/20247:51 PMGergen Mark J (Reporting)Poseida Therapeutics (Issuer)Form 4Statement of changes in beneficial ownership of securities 01/31/20241:08 PMBlackRock Inc. (Filed by)Poseida Therapeutics (Subject)Form SC 13G01/04/20243:01 PMPoseida Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 01/04/20243:02 PMGergen Mark J (Reporting)Poseida Therapeutics (Issuer)Form 4Statement of changes in beneficial ownership of securities 01/04/20243:03 PMPoseida Therapeutics (Issuer)Yarema Kristin (Reporting)Form 4Statement of changes in beneficial ownership of securities 12/11/20235:06 AMPoseida Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies STRO 10Q Form ADAP 10Q Form AGEN 10Q Form DTIL 10Q Form PASG 10Q Form ALGS 10Q Form PAHC 10Q Form RAPP 10Q Form PLRX 10Q Form TYRA 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:PSTX) was last updated on 11/8/2024 by MarketBeat.com Staff From Our Partners“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMarket Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New ForecastStarting off with a few hundred bucks, it wasn't long before I started generating $1,000 a day. Then $10,00...Opportunistic Trader | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Poseida Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Poseida Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.